Outcome of sickle cell anemia - A 4-decade observational study of 1056 patients

被引:444
作者
Powars, DR
Chan, LS
Hiti, A
Ramicone, E
Johnson, C
机构
[1] Univ So Calif, Keck Sch Med, Dept Pediat, Div Hematol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Biostat Sect, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA
[4] Univ So Calif, Keck Sch Med, Dept Internal Med, Div Hematol, Los Angeles, CA 90033 USA
关键词
D O I
10.1097/01.md.0000189089.45003.52
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Based on a prospective cohort study of 1056 patients with sickle cell anemia (Hb SS) initiated in 1959, we investigated the influence of calendar era, age, sex, and prior medical conditions on the subsequent development of irreversible organ damage and survival using the Cox regression model with time-dependent covariates adjusting for all prior occurrences. We studied 30 acute clinical events, and focused on 8 prototypic forms of irreversible organ damage. Childhood survival to age 20 years has improved from 79% for those born before 1975 to 89% for children born in or after 1975. Bone infarction was a significant risk factor for avascular necrosis (p = 0.01), and infantile dactylitis was a significant risk factor for stroke (p = 0.01). Prior hospitalized vaso-occlusive sickle crisis in adults was significantly associated with the increased rate of avascular necrosis (p < 0.001), leg ulcers (p < 0.001), sickle chronic lung disease (p < 0.001), renal failure (p < 0.005), and early death (p < 0.001). The diagnosis of clearly evident clinical conditions such as leg ulcer, osteonecrosis, and retinopathy predicted an increased likelihood of developing a more lethal form of organ damage and earlier death: 77% of patients with chronic lung disease, 75% of those with renal insufficiency, and 51% of those with stroke had a prior chronic condition. Of the 232 patients who died, 73% had 1 or more clinically recognized forms of irreversible organ damage. By the fifth decade, nearly one-half of the surviving patients (48%) had documented irreversible organ damage. End-stage renal disease (glomeruloselerosis), chronic pulmonary disease with pulmonary hypertension, retinopathy, and cerebral microinfarctions are manifestations of arterial and capillary microcirculation obstructive vasculopathy. The current study underscores the need for preventive therapy to ameliorate the progression of the sickle vasculopathy.
引用
收藏
页码:363 / 376
页数:14
相关论文
共 97 条
[1]   NON-BENIGN SICKLE-CELL ANEMIA IN WESTERN SAUDI-ARABIA [J].
ACQUAYE, JK ;
OMER, A ;
GANESHAGURU, K ;
SEJENY, SA ;
HOFFBRAND, AV .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (01) :99-108
[2]   Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination [J].
Adamkiewicz, TV ;
Sarnaik, S ;
Buchanan, GR ;
Iyer, RV ;
Miller, ST ;
Pegelow, CH ;
Rogers, ZR ;
Vichinsky, E ;
Elliott, J ;
Facklam, RR ;
O'Brien, KL ;
Schwartz, B ;
Beneden, CAV ;
Cannon, MJ ;
Eckman, JR ;
Keyserling, H ;
Sullivan, K ;
Wong, WY ;
Wang, WC .
JOURNAL OF PEDIATRICS, 2003, 143 (04) :438-444
[3]   Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease [J].
Adamkiewicz, TV ;
Mehta, PS ;
Boyer, MW ;
Kedar, A ;
Olson, TA ;
Olson, E ;
Chiang, KY ;
Maurer, D ;
Mogul, MJ ;
Wingard, JR ;
Yeager, AM .
BONE MARROW TRANSPLANTATION, 2004, 34 (05) :405-411
[4]  
Adams Junius G. Iii, 1994, P457
[5]   Stroke prevention and treatment in sickle cell disease [J].
Adams, RJ .
ARCHIVES OF NEUROLOGY, 2001, 58 (04) :565-568
[6]  
Allison PD., 2010, SURVIVAL ANAL USING
[7]   SUBARACHNOID HEMORRHAGE IN SICKLE-CELL DISEASE [J].
ANSON, JA ;
KOSHY, M ;
FERGUSON, L ;
CROWELL, RM .
JOURNAL OF NEUROSURGERY, 1991, 75 (04) :552-558
[8]   Nitric oxide-dependent generation of reactive species in sickle cell disease - Actin tyrosine nitration induces defective cytoskeletal polymerization [J].
Aslan, M ;
Ryan, TM ;
Townes, TM ;
Coward, L ;
Kirk, MC ;
Barnes, S ;
Alexander, CB ;
Rosenfeld, SS ;
Freeman, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :4194-4204
[9]   Haematopoietic cell transplantation in the treatment of sickle cell disease [J].
Atkins, RC ;
Walters, MC .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (08) :1215-1224
[10]   Mortality in sickle cell patients on hydroxyurea therapy [J].
Bakanay, SM ;
Dainer, E ;
Clair, B ;
Adekile, A ;
Daitch, L ;
Wells, L ;
Holley, L ;
Smith, D ;
Kutlar, A .
BLOOD, 2005, 105 (02) :545-547